Kathleen D. Scott Silverback Therapeutics, Inc. (SBTX) insider trading activity
Kathleen D. Scott is Chief Financial Officer of Silverback Therapeutics, Inc.. Currently has a direct ownership of 10,042 shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on Aug 21, 2025, when has been sold 12,500 shares (Common Stock) at a price of $15.0 per share, resulting in proceeds of $187,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
10K
35.26%
3M change
23.92%
12M change
Total Value Held
$0
Kathleen D. Scott Transaction History
Also insider at
KDS
Kathleen D. Scott
Chief Financial Officer
San Diego, CA